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December 20091532 AbstractsOther outcome data such as relief from claudication, wound healing, ampu-
tation, and death were also recorded.
Results: A total of 122 patients underwent an attempted SIA of an iliac
CTO, with success in 101 (83%). Technical failure was due to the inability to
re-enter the lumen in all cases. Mean age of patients was 65 years (range,
42-90 years), with a male/female ratio of 3:2. Clinical profile for this cohort
was remarkable for a high percentage of coronary artery disease (58%),
diabetes (40%), and end-stage renal disease (13%); 32 (32%) of these patients
were considered nonsurgical candidates. Indications for iliac SIA were severe
claudication in 64 (64%) and critical limb ischemia in 37 (36%). Ninety
patients underwent percutaneous SIA, and 11 patients underwent a hybrid
procedure: SIA with an ipsilateral femoral endarterectomy or femoral-to-
distal bypass. Lesion distribution was 69 common iliac arteries and 61
external iliac arteries. In 20 patients, a more distal lumen re-entry was
achieved into the superficial femoral artery (n 16) or the popliteal artery (n
 4). Stents were deployed in 82 patients (81%), with an average of 1.1
stents used (range, 0-3). True lumen re-entry was achieved with an assist
device in 15 patients (15%). Mean ankle-brachial index (ABI) was 0.52
(range, 0.12-0.95) preoperatively and 0.76 (range, 0.36-1.30) postopera-
tively.Mean ABI at last follow-up was 0.80 (range, 0.36-1.20). Claudication
improvement was documented in 46 (72%). At 1 and 2 years, primary
patency was 80% and 69%, respectively, secondary patency was 92% and 86%,
respectively, and limb salvage was 99% and 97%, respectively. The ulcers in
nine of 12 patients healed after SIA. Procedural 30-day mortality rate was 1%
(1 of 101); one patient died from an intraoperative rupture of a proximal
common iliac aneurysm. Survival rate was 93% and 65% at 1 and 4 years,
respectively, reflecting the poor health status of this cohort.
Conclusions: This study demonstrates that SIA of iliac CTO is feasible
and can be performed safely and effectively, even in high-risk patients.
Excellent patency and limb salvage rates can be achieved. In our experience,
the safety and durability of SIA makes it an attractive first-line therapy for
iliac occlusive disease.
Thoracic Endovascular Aortic Repair Broadens Treatment Eligibility
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Background:Aortic injury is the second leading cause of death in trauma.
Thoracic endovascular aortic repair (TEVAR) has recently been applied to
traumatic aortic injuries as a minimally invasive alternative to open surgery and
is gaining favor as the preferred treatment option. We sought to determine the
effect of TEVAR on national trends in the management of aortic trauma.
Methods: The Nationwide Inpatient Sample (NIS) was queried from the
years 2001 to 2007, and patients diagnosed with injury to the thoracic aorta
were selected using code 901.0 of the International Classification of Diseases
(9th ed). Patients were evaluated based on open surgical repair, TEVAR, or
nonoperative management, before and after widespread adoption of TEVAR
for aortic trauma (2001 to 2005 and 2006 to 2007; Fig). Analyses with 2 and
t tests were performed to determine trends in the use of open surgery, use of
TEVAR, inpatient death, major complications, and length of stay.
Results: The NIS documented an average of 241 inpatient admissions
with a diagnosis of thoracic aortic trauma per year, corresponding to an
estimated 1180 yearly admissions in the United States. A comparison of the
time periods 2001 to 2005 and 2006 to 2007 showed a significant increase in
TEVAR (P .001) with a concomitant decrease in open repair (P .001) in
2006 to 2007. The overall number of interventions significantly increased (P
● Rates of open surgical repair, thoracic endovascular aneurysm
repair (TEVAR), or nonoperative management, before and after
widespread adoption of TEVAR for aortic trauma.001). The overall mortality rate significantly decreased (24.8% vs 18.7%, P 
.006), corresponding to a trend toward improved survival in the nonoperative
group (27.8% vs 25.0%, P .053). There was no improvement in open repair
mortality rates between the two time periods. The TEVAR group had a
significantly higher percentage of patients with intra-abdominal injuries (85% vs
70%,P .002), and hemothorax (48% vs 36%,P .038) than the open surgery
group; however, there were no differences in the number of closed head injuries
or major orthopedic fractures. The open surgery group had higher rates of
postoperative respiratory failure (61%vs 50%,P .047), but nodifferenceswere
seen in paraplegia or renal failure. Overall in-hospital mortality was 22.9%:
26.3% among the nonoperative group, 12.2%with open repair, and 10.4%with
TEVAR. The difference in mortality between open repair and TEVAR was not
significant. Length of stay was 15 days in the TEVAR group compared 22 days
with open repair (P .001).
Conclusions: Among patients with aortic trauma, the use of TEVAR has
decreased the rate of open aortic repair and increased the overall number of
patients receiving intervention. Since the wider adoption of TEVAR in 2006,
fewer patients are managed nonoperatively, and overall survival has improved.
There was no difference in mortality between TEVAR and open repair in our
study, which may reflect more aggressive treatment in the TEVAR group of
those who previously would not have been offered intervention due to injury
severity. Evidence suggests that TEVAR has made a significant impact in the
management of this trauma population nationally, although more studies are
indicated to further clarify its role in traumatic aortic disruption.
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Background: In 1992, the Centers for Medicare and Medicaid Services
instituted the Resource Based Relative Value Scale (RBRVS) system to deter-
mine physician reimbursement, incorporating three components of physician
services: physician work, practice expense, and liability insurance. The relative
value units (RVU) are assigned to eachCurrent Procedural Terminology (CPT)
code and are intended to reflect the time and intensity of work. This RVU is the
core value that determines the “fair” reimbursement for physician work. Does
this system accurately balance the true time it takes for each procedure? The
purpose of this study was to determine how well this system distributes pay-
ments for hospital-based procedures during a 12-month period.
Methods: From July 1, 2008, to June 30, 2009, procedural times for
all vascular interventions (time into room until time out of room) were
recorded. Additionally recorded were 15 minutes for administrative time on
the day of the procedure, each hospital day, and all office visits within the
global period (the total care time). The actual physician’s total fee collected
for each of these procedures was divided by the total care time to determine
the payment per unit time. We did not isolate unbundled codes, but rather
reported the total reimbursement for the entire procedure to more accu-
rately reflect the typical vascular experience.
Results: Data were collected on all 1103 procedures performed during this
period. The analysis excluded 37 patients (35 no payments received, 2 incomplete
times recorded). Carrier distribution was 75%Medicare and 25% private.
Table. Reimbursement per unit time is reflected in the
following chart for each of the major procedures:
Procedure Number
OR time
(hrs)
Post-op
days
Consult
time (hrs)
Reimbursement
Total$ $/h
Aortic bypass 15 65.9 52 22.75 31,809 359
Aortic endograft 25 66.9 36 27.25 55,807 593
Abdominal endovascular 39 62.4 0 9.75 44,200 612
Carotid endarterectomy 118 242.9 150 116.00 137,559 383
Carotid stent 20 27.4 20 13.25 26,419 650
Cerebral arteriography 7 8.2 0 1.75 4867 487
Bypass graft revision
Open 6 14.8 15 7.25 8439 382
Endo 5 6.1 0 1.25 4523 617
LE bypass 45 166.5 145 74.00 70,211 292
L. extremity endarterectomy 23 54.4 34 23.75 38,452 492
L. extremity endovascular 179 270.7 0 44.75 192,139 609
L. extremity thrombectomy 13 32.1 57 23.00 20,166 366
Dialysis graft revision
Open 46 73.5 56 39.75 32,019 283
Endo 119 125.5 4 35.00 85,725 534
Dialysis access 76 127.7 15 56.25 49,328 268
L. extremity arteriography 106 117.4 0 26.50 52,310 364
Fistulogram 12 9,7 0 3.00 3261 245
Caval filter insert/remove 22 17.3 39 15.50 19,891 606
L. extremity venous 30 34.8 0 15.25 19,498 389
L. extremity amputation 47 65.5 244 90.25 34,686 223
Visceral endovascular 32 43.3 0 8.00 35,020 682
